Arm Exercise Capacity, Muscle Strength and Activities of Daily Living in Patients with Fibromyalgia Syndrome
NCT ID: NCT06678932
Last Updated: 2024-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
36 participants
OBSERVATIONAL
2024-11-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Posture, Balance, Gait Disorders in Patients With Fibromyalgia
NCT06245226
The Relationship Between Fatigue and Physical Activity Level in Patients With Multiple Sclerosis
NCT03255460
Investigation of Factors Affecting Upper Extremity Function in Healthy Young Adults
NCT06937879
Investigation of the Effects of Proprioceptive Neuromuscular Facilitation Exercises in Patients With Myasthenia Gravis
NCT06158815
Effect of Arm Ergometer Exercise Training on Upper Extremity Function in People With Multiple Sclerosis.
NCT05571631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fibromyalgia syndrome
No interventions assigned to this group
Healthy controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being aged 18-65
* Stable use of medication for at least 3 months or longer
* Volunteering to participate in the study
* Being aged 18-65
* Volunteering to participate in the study
Exclusion Criteria
* Failure to cooperate with tests to be performed
* Presence of exercise test contraindication
* Having a chronic or systemic disease
* Failure to cooperate with tests to be performed
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kirsehir Ahi Evran Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merve Firat
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Basak Kavalci Kol
Role: STUDY_CHAIR
Kirsehir Ahi Evran University
Figen Tuncay
Role: STUDY_CHAIR
Kirsehir Ahi Evran University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kirsehir Ahi Evran University
Kırşehir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-13/115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.